.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Michael Chernew, PhD, Discusses Challenges in Oncology Management

Published on: November 16, 2012

Conference | Translating Evidence-Based Research into Value-Based Decisions in Oncology

Michael Chernew, PhD, Professor of Health Care Policy, Harvard Medical School, Vice Chairman, MEDPAC, Co-Editor-in-Chief, The American Journal of Managed Care, says that patients want access to expensive drugs that can help expand and improve their lives.

Professor of Health Care Policy,

Harvard Medical School,

Vice Chairman, MEDPAC,

Co-Editor-in-Chief, The American Journal of Managed Care, says that patients want access to expensive drugs that can help expand and improve their lives. A big challenge is understanding which of these drugs are valuable while managing their use. Dr. Chernew says determining what is high and low value is one of the biggest challenges payers face in oncology management.

Michael Chernew, PhD,

This video was taken on November 16 at AJMC's Translating Evidence-Based Research Into Value-Based Decisions in Oncology.